Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Epidermal growth factor helps hair recover after chemotherapy.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

EDA2R gene linked to hair loss.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Erlotinib can cause excessive eyelash growth.

Double-stranded RNA helps regenerate hair follicles by increasing retinoic acid production and signaling.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

A genetic change in the EDAR gene causes the unique hair traits found in East Asians.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

RORA boosts autophagy in hair follicle stem cells, potentially aiding hair growth.

Reduced EGFR signaling delays hair cycle and reduces fat growth, but hair development remains normal.

A new topical treatment for hair loss is effective and safe with faster results.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.